Naseem Zojwalla insider trades
Open-market stock purchases and sales by Naseem Zojwalla, CHIEF MEDICAL OFFICER at Olema Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 1, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 2, 2026 | OLMA Olema Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 2, 2026 | OLMA Olema Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 23, 2025 | OLMA Olema Pharmaceuticals, Inc | Sold | $2.8M |
| Dec 23, 2025 | OLMA Olema Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 22, 2025 | OLMA Olema Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 22, 2025 | OLMA Olema Pharmaceuticals, Inc | Sold | $2.8M |
| Dec 22, 2025 | OLMA Olema Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 19, 2025 | OLMA Olema Pharmaceuticals, Inc | Sold | $1.6M |
| Dec 19, 2025 | OLMA Olema Pharmaceuticals, Inc | Sold | $374K |
| Dec 19, 2025 | OLMA Olema Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- OLMA Olema Pharmaceuticals, Inc: 10 sales, last Feb 2, 2026